JP Stock MarketDetailed Quotes

4551 Torii Pharmaceutical

Watchlist

4835
+85+1.79%

20min DelayMarket Closed Nov 29 15:30 JST

139.25BMarket Cap32.98P/E (Static)

Torii Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

11.84%15.02B

6.98%14.86B

13.89%13.45B

11.75%54.64B

14.18%15.51B

9.99%13.43B

14.38%13.89B

7.76%11.81B

4.06%48.89B

0.21%13.58B

Cost of revenue

12.34%8.23B

9.78%8.21B

19.07%7.49B

16.97%29.85B

22.83%8.75B

15.49%7.33B

17.35%7.48B

10.84%6.29B

12.66%25.52B

10.28%7.12B

Gross profit

11.25%6.79B

3.72%6.64B

7.99%5.96B

6.04%24.79B

4.61%6.76B

4.06%6.11B

11.12%6.41B

4.44%5.52B

-3.94%23.38B

-8.93%6.46B

Operating expense

19.68%5.27B

9.58%4.89B

-23.15%4.58B

10.74%19.75B

-1.06%4.93B

-1.78%4.41B

1.90%4.46B

49.25%5.96B

-9.38%17.83B

-10.88%4.98B

Staff costs

3.28%1.26B

-7.58%1.26B

-3.97%1.21B

1.88%5.16B

-5.37%1.32B

3.04%1.22B

10.49%1.36B

0.40%1.26B

0.56%5.07B

3.10%1.4B

Selling and administrative expenses

42.53%553M

-8.08%364M

-11.41%334M

9.95%3.62B

9.70%2.45B

-2.51%388M

14.78%396M

22.40%377M

-21.47%3.29B

60.24%2.24B

-Selling and marketing expense

42.53%553M

-8.08%364M

-11.41%334M

0.06%1.58B

-20.57%421M

-2.51%388M

14.78%396M

22.40%377M

-62.24%1.58B

-62.03%530M

-General and administrative expense

----

19.10%2.03B

----

--1.71B

----

Research and development costs

109.30%833M

133.43%831M

-74.14%532M

110.11%3.49B

18.71%679M

-21.34%398M

-12.53%356M

1,068.75%2.06B

99.64%1.66B

78.19%572M

Depreciation and amortization

----

-6.84%218M

----

-9.65%234M

----

-Depreciation

----

-6.84%218M

----

-9.65%234M

----

Other operating expenses

9.47%2.63B

3.71%2.43B

10.55%2.5B

-4.21%7.27B

-52.77%256M

0.08%2.4B

-1.92%2.35B

0.49%2.27B

-18.99%7.59B

-76.01%542M

Operating profit

-10.58%1.52B

-9.70%1.76B

417.43%1.38B

-9.09%5.04B

23.76%1.83B

22.99%1.7B

40.14%1.95B

-133.67%-436M

19.02%5.55B

-1.66%1.48B

Net non-operating interest income (expenses)

19.23%93M

13.89%82M

20.97%75M

71.86%287M

33.93%75M

73.33%78M

157.14%72M

63.16%62M

15.97%167M

69.70%56M

Non-operating interest income

19.23%93M

13.89%82M

20.97%75M

71.86%287M

33.93%75M

73.33%78M

157.14%72M

63.16%62M

15.97%167M

69.70%56M

Non-operating interest expense

--0

Net investment income

4,650.00%91M

74.63%-17M

-188.24%-49M

-15.38%11M

6.59%97M

-106.67%-2M

-63.41%-67M

74.63%-17M

-82.89%13M

42.19%91M

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

11.11%-8M

0.00%-9M

-1,168.42%-241M

121.60%277M

2,193.33%314M

35.71%-9M

-105.20%-9M

0.00%-19M

226.26%125M

0.00%-15M

Income from associates and other participating interests

Special income (charges)

-9M

-100.00%-2M

-500.00%-6M

-1,700.00%-36M

-1,600.00%-34M

-1M

94.87%-2M

85.71%-2M

Less:Other special charges

--9M

100.00%2M

500.00%6M

1,700.00%36M

--34M

--0

--1M

-92.59%2M

----

Other non-operating income (expenses)

0.00%5M

-133.33%-2M

116.53%20M

-63.64%4M

-16.67%5M

103.60%5M

500.00%6M

-503.33%-121M

120.00%11M

Income before tax

-4.51%1.69B

-6.63%1.82B

386.42%1.16B

-2.25%5.59B

41.06%2.28B

22.21%1.77B

38.04%1.95B

-132.50%-405M

20.03%5.72B

2.60%1.62B

Income tax

-20.98%388M

-16.70%474M

342.24%281M

-17.15%1.47B

0.00%529M

11.85%491M

27.58%569M

-131.87%-116M

27.73%1.78B

20.50%529M

Net income

1.72%1.3B

-2.26%1.34B

404.86%878M

4.44%4.12B

60.94%1.75B

26.81%1.28B

42.68%1.37B

-132.65%-288M

16.89%3.94B

-4.23%1.09B

Net income continuous operations

1.80%1.3B

-2.47%1.34B

404.15%879M

4.46%4.12B

61.03%1.75B

26.71%1.28B

42.89%1.38B

-132.77%-289M

16.86%3.94B

-4.31%1.09B

Noncontrolling interests

Net income attributable to the company

1.72%1.3B

-2.26%1.34B

404.86%878M

4.44%4.12B

60.94%1.75B

26.81%1.28B

42.68%1.37B

-132.65%-288M

16.89%3.94B

-4.23%1.09B

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

1.72%1.3B

-2.26%1.34B

404.86%878M

4.44%4.12B

60.94%1.75B

26.81%1.28B

42.68%1.37B

-132.65%-288M

16.89%3.94B

-4.23%1.09B

Gross dividend payment

Basic earnings per share

1.75%46.39

-2.43%47.77

404.18%31.27

4.42%146.6

60.93%62.33

26.74%45.59

42.78%48.96

-132.74%-10.28

16.87%140.39

-4.25%38.73

Diluted earnings per share

1.75%46.3867

-2.31%47.77

404.18%31.27

4.42%146.6

60.90%62.3016

26.74%45.59

42.65%48.8985

-132.74%-10.28

16.87%140.39

-4.25%38.7202

Dividend per share

20.00%60

20.00%120

-7.89%70

108.33%50

108.33%100

216.67%76

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	11.84%15.02B	6.98%14.86B	13.89%13.45B	11.75%54.64B	14.18%15.51B	9.99%13.43B	14.38%13.89B	7.76%11.81B	4.06%48.89B	0.21%13.58B
Cost of revenue	12.34%8.23B	9.78%8.21B	19.07%7.49B	16.97%29.85B	22.83%8.75B	15.49%7.33B	17.35%7.48B	10.84%6.29B	12.66%25.52B	10.28%7.12B
Gross profit	11.25%6.79B	3.72%6.64B	7.99%5.96B	6.04%24.79B	4.61%6.76B	4.06%6.11B	11.12%6.41B	4.44%5.52B	-3.94%23.38B	-8.93%6.46B
Operating expense	19.68%5.27B	9.58%4.89B	-23.15%4.58B	10.74%19.75B	-1.06%4.93B	-1.78%4.41B	1.90%4.46B	49.25%5.96B	-9.38%17.83B	-10.88%4.98B
Staff costs	3.28%1.26B	-7.58%1.26B	-3.97%1.21B	1.88%5.16B	-5.37%1.32B	3.04%1.22B	10.49%1.36B	0.40%1.26B	0.56%5.07B	3.10%1.4B
Selling and administrative expenses	42.53%553M	-8.08%364M	-11.41%334M	9.95%3.62B	9.70%2.45B	-2.51%388M	14.78%396M	22.40%377M	-21.47%3.29B	60.24%2.24B
-Selling and marketing expense	42.53%553M	-8.08%364M	-11.41%334M	0.06%1.58B	-20.57%421M	-2.51%388M	14.78%396M	22.40%377M	-62.24%1.58B	-62.03%530M
-General and administrative expense	----	----	----	19.10%2.03B	----	----	----	----	--1.71B	----
Research and development costs	109.30%833M	133.43%831M	-74.14%532M	110.11%3.49B	18.71%679M	-21.34%398M	-12.53%356M	1,068.75%2.06B	99.64%1.66B	78.19%572M
Depreciation and amortization	----	----	----	-6.84%218M	----	----	----	----	-9.65%234M	----
-Depreciation	----	----	----	-6.84%218M	----	----	----	----	-9.65%234M	----
Other operating expenses	9.47%2.63B	3.71%2.43B	10.55%2.5B	-4.21%7.27B	-52.77%256M	0.08%2.4B	-1.92%2.35B	0.49%2.27B	-18.99%7.59B	-76.01%542M
Operating profit	-10.58%1.52B	-9.70%1.76B	417.43%1.38B	-9.09%5.04B	23.76%1.83B	22.99%1.7B	40.14%1.95B	-133.67%-436M	19.02%5.55B	-1.66%1.48B
Net non-operating interest income (expenses)	19.23%93M	13.89%82M	20.97%75M	71.86%287M	33.93%75M	73.33%78M	157.14%72M	63.16%62M	15.97%167M	69.70%56M
Non-operating interest income	19.23%93M	13.89%82M	20.97%75M	71.86%287M	33.93%75M	73.33%78M	157.14%72M	63.16%62M	15.97%167M	69.70%56M
Non-operating interest expense	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Net investment income	4,650.00%91M	74.63%-17M	-188.24%-49M	-15.38%11M	6.59%97M	-106.67%-2M	-63.41%-67M	74.63%-17M	-82.89%13M	42.19%91M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets	11.11%-8M	0.00%-9M	-1,168.42%-241M	121.60%277M	2,193.33%314M	35.71%-9M	-105.20%-9M	0.00%-19M	226.26%125M	0.00%-15M
Income from associates and other participating interests
Special income (charges)	-9M	-100.00%-2M	-500.00%-6M	-1,700.00%-36M	-1,600.00%-34M	0	-1M	-1M	94.87%-2M	85.71%-2M
Less:Other special charges	--9M	100.00%2M	500.00%6M	1,700.00%36M	--34M	--0	--1M	--1M	-92.59%2M	----
Other non-operating income (expenses)	0.00%5M	0.00%5M	-133.33%-2M	116.53%20M	-63.64%4M	-16.67%5M	103.60%5M	500.00%6M	-503.33%-121M	120.00%11M
Income before tax	-4.51%1.69B	-6.63%1.82B	386.42%1.16B	-2.25%5.59B	41.06%2.28B	22.21%1.77B	38.04%1.95B	-132.50%-405M	20.03%5.72B	2.60%1.62B
Income tax	-20.98%388M	-16.70%474M	342.24%281M	-17.15%1.47B	0.00%529M	11.85%491M	27.58%569M	-131.87%-116M	27.73%1.78B	20.50%529M
Net income	1.72%1.3B	-2.26%1.34B	404.86%878M	4.44%4.12B	60.94%1.75B	26.81%1.28B	42.68%1.37B	-132.65%-288M	16.89%3.94B	-4.23%1.09B
Net income continuous operations	1.80%1.3B	-2.47%1.34B	404.15%879M	4.46%4.12B	61.03%1.75B	26.71%1.28B	42.89%1.38B	-132.77%-289M	16.86%3.94B	-4.31%1.09B
Noncontrolling interests
Net income attributable to the company	1.72%1.3B	-2.26%1.34B	404.86%878M	4.44%4.12B	60.94%1.75B	26.81%1.28B	42.68%1.37B	-132.65%-288M	16.89%3.94B	-4.23%1.09B
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	1.72%1.3B	-2.26%1.34B	404.86%878M	4.44%4.12B	60.94%1.75B	26.81%1.28B	42.68%1.37B	-132.65%-288M	16.89%3.94B	-4.23%1.09B
Gross dividend payment
Basic earnings per share	1.75%46.39	-2.43%47.77	404.18%31.27	4.42%146.6	60.93%62.33	26.74%45.59	42.78%48.96	-132.74%-10.28	16.87%140.39	-4.25%38.73
Diluted earnings per share	1.75%46.3867	-2.31%47.77	404.18%31.27	4.42%146.6	60.90%62.3016	26.74%45.59	42.65%48.8985	-132.74%-10.28	16.87%140.39	-4.25%38.7202
Dividend per share	0	20.00%60	0	20.00%120	-7.89%70	0	108.33%50	0	108.33%100	216.67%76
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data